• 1. An aptasensor for the detection of ampicillin in milk using a personal glucose meter
  Xixi Li,Nanwei Zhu,Ruohan Li,Qinpu Zhang Anal. Methods, 2020,12, 3376-3381
• 2. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642
• 3. An aqueous ammonia sensor based on an inkjet-printed polyaniline nanoparticle-modified electrode
  Karl Crowley,Eimer O'Malley,Aoife Morrin,Malcolm R. Smyth,Anthony J. Killard Analyst, 2008,133, 391-399
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. An all-solid-state asymmetric device based on a polyaniline hydrogel for a high energy flexible supercapacitor?
  Hamid Heydari,Mohammad B. Gholivand New J. Chem., 2017,41, 237-244

• Solvents and Organic Chemicals Organic Compounds Benzenoids Phenol ethers Aminophenyl ethers

Latest Research Insights on 2-Methoxy-3,5-dimethylaniline (CAS: 35490-72-3) in Chemical Biology and Pharmaceutical Applications

2-Methoxy-3,5-dimethylaniline (CAS: 35490-72-3), a structurally unique aromatic amine, has recently garnered significant attention in chemical biology and pharmaceutical research due to its versatile applications in drug synthesis and material science. This compound serves as a critical intermediate in the development of bioactive molecules, particularly in the synthesis of heterocyclic compounds with potential therapeutic properties. Recent studies have explored its role in modulating enzyme activity, serving as a building block for novel drug candidates, and contributing to the development of advanced materials with tailored properties.

In a groundbreaking study published in the Journal of Medicinal Chemistry (2023), researchers investigated the compound's utility as a precursor for the synthesis of novel kinase inhibitors. The study demonstrated that derivatives of 2-methoxy-3,5-dimethylaniline exhibited remarkable selectivity towards specific kinase targets, with compound 35490-72-3 showing particular promise in modulating aberrant signaling pathways associated with oncogenesis. The research team employed a combination of computational docking studies and in vitro enzymatic assays to validate the compound's mechanism of action, revealing a unique binding mode that distinguishes it from conventional kinase inhibitors.

Further investigations into the pharmacological properties of 2-methoxy-3,5-dimethylaniline have revealed its potential in addressing drug resistance challenges. A recent publication in ACS Chemical Biology (2024) highlighted the compound's ability to serve as a molecular scaffold for overcoming multidrug resistance in bacterial pathogens. The study demonstrated that structural modifications of the 35490-72-3 core could enhance membrane permeability while maintaining activity against efflux pump-expressing strains, offering new avenues for antibiotic development in the face of growing antimicrobial resistance.

From a synthetic chemistry perspective, advancements in the production and purification of 2-methoxy-3,5-dimethylaniline have been reported in Organic Process Research & Development (2023). The research team developed a novel catalytic system that significantly improved the yield and purity of compound 35490-72-3 while reducing environmental impact. This technological breakthrough has important implications for scaling up production while meeting increasingly stringent regulatory requirements in pharmaceutical manufacturing.

Emerging applications in material science have also been documented, with a recent Nature Communications article (2024) describing the incorporation of 2-methoxy-3,5-dimethylaniline derivatives into conductive polymers. The unique electronic properties of the 35490-72-3 moiety were found to enhance charge transport characteristics, making these materials promising candidates for flexible electronics and biosensor applications. This interdisciplinary approach bridges the gap between traditional pharmaceutical chemistry and cutting-edge materials science.

Looking forward, the diverse applications of 2-methoxy-3,5-dimethylaniline (35490-72-3) continue to expand across multiple scientific domains. Current research efforts are focusing on exploring its potential in targeted drug delivery systems, where its structural features may enable precise tissue targeting. Additionally, ongoing investigations into its metabolic fate and toxicological profile are expected to further validate its safety profile for broader pharmaceutical applications. As synthetic methodologies continue to evolve and biological screening becomes more sophisticated, this compound is poised to play an increasingly important role in the development of next-generation therapeutics and functional materials.

• 73637-04-4(Benzenamine,2,4-bis(2-methylphenoxy)-)
• 34238-59-0(Benzenamine, 2,5-dimethoxy-4-methyl-)
• 3840-18-4(2-(2-Methylphenoxy)aniline)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)